20/20 Biolabs, Inc.
AIDX- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001139685
No open-market purchases or sales by 20/20 Biolabs, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $297.1K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding 20/20 Biolabs, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 7 | 15 | +8 |
| Shares | 300.4K | 540.6K | +240.2K (+80.0%) |
| Value | $564.8K | $297.1K | −$267.7K (−47.4%) |
New holders (10)
Institutions that held 20/20 Biolabs, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 89,273 | $49.0K | 0.00% |
| Vanguard Fiduciary Trust Co | 52,087 | $28.6K | 0.00% |
| Geode Capital Management, LLC | 49,141 | $27.0K | 0.00% |
| Atlantic Union Bankshares Corp | 35,099 | $19.3K | 0.00% |
| Vanguard Capital Management LLC | 24,530 | $13.5K | 0.00% |
| Bank of America Corp | 13,024 | $7.15K | 0.00% |
| Susquehanna International Group, LLP | 10,014 | $5.50K | 0.00% |
| McDonald Partners LLC | 2,800 | $1.54K | 0.00% |
| Signaturefd, LLC | 767 | $422 | 0.00% |
| Morgan Stanley | 283 | $156 | 0.00% |
Sold out (2)
Institutions that held 20/20 Biolabs, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| XTX Topco Ltd | 10,329 | $19.4K |
| MAI Capital Management | 1,000 | $1.88K |